利培酮和奥氮平及氟哌啶醇对精神分裂症患者血清催乳素及体质量的影响
被引量:11
摘要
我们观察比较了2种第2代抗精神病药(利培酮和奥氮平)与第1代抗精神病药(氟哌啶醇)对精神分裂症患者血清催乳激素(PRL)及体质量的影响。
出处
《中华精神科杂志》
CAS
CSCD
北大核心
2010年第4期256-256,共1页
Chinese Journal of Psychiatry
参考文献3
-
1Davis JM.The choice of drugs for schizophrenia.N Engl J Med,2006,354:518-520.
-
2Wieck A,Haddad P.Hyperprolactinaemia caused by antipsychotic drugs.BMJ,2002,324:250-252.
-
3Strassnig M,Miewald J,Keshavan M,et al.Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons:one-year analysis.Schizophr Res,2007,93 (1-3):90-98.
同被引文献120
-
1蔡旭明,阮洪梅,任季冬,等奥氮平联用利培酮对精神分裂症患者糖脂代谢及瘦素影响的临床研究[J].四川医学,2012,33(7):1244-1245.
-
2Harvey PD,Pappadopulos E, Lombardo I, et al. Reduction of functional disability with atypical antipsychotic treatment : a randomized long term comparison of ziprasidone and haloperidol. Schizophr Res ,2009,115 ( 1 ) :24-29.
-
3Koro CE, Fedder DO, Litalien GJ, et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia:population based nested case-control study. BMJ,2009,325 ( 5 ) :243.
-
4Simpson GM, Glick ID, Weiden PJ, et al. Randomized, controlled, double - blindmulticenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatientswith schizophrenia or schizoaffective disorder. Am J Psychiatry, 2011, 161(10) :1837.
-
5Cohen-Corys, Kidane AI, Shirkey N J, et al. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev bleurobiol,2010,70 (5) :271-288.
-
6Newcomer JW. Metabolic considerations in the use of an-tipsychotic medications: a review of recent evidence[J]. J Clin Psychiatry,2007,68(Suppl 1):20-27.
-
7Harvey PD,Pappadopulos E, Lombardo I, et al. Reduction of functional disability with atypical antipsychotic treatment:a randomized long term comparison of ziprasidone and haloperidol[J]. Schizophr Res, 2009,115 (1): 24-29.
-
8Villari V, Rocca P, Fonzo V, et al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation[J]. Prog Neuropsychopharmaeol Biol Psychiatry, 2008, 32 (2): 405-413.
-
9Koro CE,Fedder DO,L'italien GJ ,et al. Assessment ot independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study[J]. BMJ, 2002,325 : 243-247.
-
10Lindenmayer JP, Czobor P, Volavka J, et al. Changes in glucose and cholesterol levels in patients with schizophre- nia treated with typical or atypical antipsychitics[J]. Am J Psychiatry, 2003,160 (2): 290-296.
引证文献11
-
1于鲁璐,王学义,金圭星,谭莉,安翠霞.男性精神分裂症患者雌激素水平及药物影响研究[J].中国神经精神疾病杂志,2012,38(12):742-746. 被引量:9
-
2杜志广,谭新国,刘存强.奥氮平联合利培酮对精神分裂症患者血清同型半胱氨酸水平的影响[J].中国基层医药,2013,20(17):2574-2576. 被引量:5
-
3王祥.利培酮及奥氮平对老年精神分裂症患者糖、脂代谢、血清瘦素及催乳素的影响[J].贵阳中医学院学报,2013,35(6):144-146. 被引量:19
-
4张星亮,李小云,高玲玲,倪耀文.三种非典型抗精神病药对精神分裂症首发患者代谢影响的临床研究[J].中国药物与临床,2014,14(1):117-119. 被引量:14
-
5王祥.奥氮平联用齐拉西酮对老年精神分裂症患者糖脂代谢血清瘦素及催乳素水平的影响[J].检验医学与临床,2014,11(1):42-44. 被引量:14
-
6程德君.奥氮平联用利培酮对精神分裂症患者糖脂代谢的影响[J].江苏医药,2014,40(5):583-585. 被引量:13
-
7仝炅,郭朝霞,王福光.奥氮平与利培酮治疗精神分裂症的随机对照研究[J].中国卫生工程学,2014,13(2):165-167. 被引量:3
-
8刘建君,孙菊水,沈鑫华,郭纬刚,支胜利,宋光明.利培酮和奎硫平治疗对女性精神分裂症患者生殖激素和骨密度及体质量的影响[J].中华精神科杂志,2014,47(5):288-292. 被引量:25
-
9刘怀斌,侯凌峰,王小红,张志荣.奥氮平与利培酮对精神分裂症患者脂代谢的影响[J].河北北方学院学报(自然科学版),2016,32(6):4-7. 被引量:2
-
10朱平.住院精神疾病患者的慢性躯体合并症调查分析[J].神经损伤与功能重建,2018,13(6):311-312. 被引量:4
二级引证文献110
-
1罗利玲,刘桂萍,黎爱云.氯氮平和奎硫平对首发精神分裂症体质量、血糖及瘦素的影响[J].湖南师范大学学报(医学版),2020,17(1):101-104. 被引量:7
-
2李春娟,张景崴,曹静.齐拉西酮与奥氮平对女性精神分裂症患者的代谢影响及疗效研究[J].医学信息,2017,30(A01):71-72. 被引量:1
-
3李国宁.奥氮平与利培酮治疗老年精神分裂症的疗效研究[J].医学信息,2017,30(3):125-126.
-
4田卫兰.抗精神病药对精神分裂症患者甲状腺激素影响探析[J].医学信息(医学与计算机应用),2014,0(21):50-50. 被引量:1
-
5冯玉明.对比奥氮平与齐拉西酮治疗精神分裂症的效果观察[J].中国医药科学,2014,4(9):89-91.
-
6宋建成,吉中孚.对精神分裂症症状认识的演变[J].国外医学(精神病学分册),2000,27(1):23-27. 被引量:26
-
7石珺,汪崇文,刘浩.老年2型糖尿病患者合并脑梗塞的血尿酸改变[J].实用老年医学,2000,14(1):40-40. 被引量:4
-
8童爱群.利培酮口服液治疗老年器质性精神障碍效果观察[J].中国医药导报,2014,11(11):68-70. 被引量:8
-
9马宇行.92例精神分裂症患者性激素变化水平动态观察[J].黑龙江医学,2014,38(6):638-639. 被引量:4
-
10陈国强.精神疾病应用利培酮合并小剂量氯氮平治疗的临床疗效观察[J].中国现代药物应用,2014,8(14):94-95. 被引量:2
-
1亓高超.氨磺必利和喹硫平对首发女性精神分裂症性激素、骨密度及体质量的影响[J].精神医学杂志,2016,29(2):126-128. 被引量:15
-
2潘小儿,胡央儿.齐拉西酮治疗复发精神分裂症患者的疗效观察[J].中国基层医药,2012,19(7):1054-1055. 被引量:1
-
3洪文轲.男性急性脑卒中患者下丘脑—垂体—性腺轴功能测定及血清催乳激素水平观察[J].浙江医学,2002,24(3):135-136.
-
4李媛媛,常永霞,蒋毅,邹玉安.脑梗死患者血浆和脑脊液催乳激素、卵泡刺激素、促黄体生成激素、雌二醇水平与疾病进展的对比研究[J].河北中医,2015,37(2):306-310. 被引量:4
-
5刘汝宏,丛志强.丛集性头痛患者内分泌功能的检测[J].中风与神经疾病杂志,2001,18(4):237-239.
-
6刘汝宏,丛志强.丛集性头痛发病机制的探讨[J].中华神经科杂志,2001,34(2):113-113. 被引量:10
-
7齐文耀.双相情感障碍男性患者血浆白蛋白、总胆红素和血清炎性因子、性腺激素水平变化及临床意义[J].中国基层医药,2017,24(5):721-724. 被引量:11
-
8Zhi-ling ZHOU,Xin LI,Huai-yan PENG,Xi-yong YU,Ming YANG,Feng-li SU,Feng WANG,Rong-hua ZHU,Chun-yu DENG,Qiu-xiong LIN,Chuan-yue WANG,Wen-biao LI,Shu-guang LIN,Huan-de LI.Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia[J].Acta Pharmacologica Sinica,2006,27(3):381-386. 被引量:3